FIELD: medicine.
SUBSTANCE: invention relates to a method for increasing osseous mass in osteoporosis disease. Method involves using sets containing standard doses of bisphosphonates in the amount sufficient for using in "impact" period from 7 to 180 days, and standard doses of bisphosphonate for the following using in supporting period. Bisphosphonate is chosen from group consisting of risedronate, alendronic acid, pamidronate, tiludronate, clodronate, cimadronate, ibandronate, zoledronate and their salts and esters. Standard doses of bisphosphonate in "impact" period are by 3-6 times higher as compared with standard doses of bisphosphonate in supporting period. Using sets of bisphosphonates in the given ratio of doses in "impact" and supporting periods provides increasing the osseous mass in osteoporosis of different genesis.
EFFECT: improved treatment method.
6 cl, 4 ex
